Skip to main content
. 2023 Aug 14;16:2223–2227. doi: 10.2147/CCID.S424310

Figure 3.

Figure 3

Questionnaire evaluation of abrocitinib before and after treating patients with EPPP. Pruritus was assessed using the visual analog scale (VAS) and the 12-item pruritus severity scale (12-PSS), and data on quality of life were assessed using the dermal life quality index (DLQI).